90/219/EEC - Contained use of genetically modified micro-organisms
Council Directive 90/219/EEC establishes common measures for the contained use of genetically modified micro-organisms (GMMs) within the European Community to protect human health and the environment. It defines GMMs, containment practices, and classifies operations by risk levels. The directive mandates prior risk assessments by users, notifications to competent authorities before use, and compliance with safety and containment protocols. Depending on risk classification, users must submit detailed information on GMMs, personnel, installations, waste management, and emergency plans. Competent authorities review submissions, may require modifications, and grant consent especially for higher-risk operations. Provisions require emergency preparedness, accident reporting, and public information where relevant. Cooperation among Member States on accident management and information exchange is mandated. The directive exempts certain transportation and uses under other Community legislation. Regular reporting to the Commission ensures monitoring of GMM use and experience, while confidentiality of sensitive data is protected. The directive supports safe biotechnology development consistent with environmental and public health considerations, adapting to scientific progress through a committee and periodic reviews.
Purpose
Council Directive 90/219/EEC establishes a legal framework for the contained use of genetically modified micro-organisms (GMMs) within the European Community. Its primary aim is to protect human health and the environment by preventing and controlling any potential adverse effects associated with the contained use of GMMs. Contained use refers to any operation involving the genetic modification, culture, storage, use, transport, destruction, or disposal of GMMs involving physical and/or chemical/biological barriers to limit their contact with humans and the environment.
The Directive addresses the safe development and application of biotechnology, ensuring common EU measures for risk evaluation, reduction, and containment to prevent the unintended release of GMMs and associated hazards.
Key Obligations
Risk Assessment: Users must perform prior risk assessments for any contained use of GMMs, considering human health and environmental risks based on criteria in Annex III. Records of these assessments must be maintained and available to competent authorities.
Classification of GMMs: GMMs are classified into two groups based on their risk profile (Group I: lower risk; Group II: higher risk) according to criteria provided in Annex II. This classification informs safety and containment measures.
Containment Measures: For Group I GMMs, good microbiological practice and occupational safety principles must be followed. For Group II, more stringent containment protocols (Annex IV) apply, with periodic review of containment measures based on new scientific knowledge.
Notification and Authorisation:
- Before first use of a specific installation for GMM operations, users must notify competent authorities with detailed information (Annex V A).
- For Type A operations (small-scale, research, teaching), records or notifications are required depending on GMM group.
- For Type B operations (industrial/commercial scale), detailed notifications must be submitted, including information on GMMs, personnel, installation, waste management, safety, and emergency plans (Annex V B, C, D).
- Competent authorities review notifications for completeness, classification correctness, and safety adequacy.
- Operations with Group I GMMs may proceed after 60-90 days unless restrictions apply; operations with Group II require explicit consent before proceeding.
Accident Prevention and Emergency Planning:
- Users must establish emergency plans and communicate safety and behavior information to potentially affected persons.
- Immediate reporting of any accident involving significant unintended release is required, including detailed information about the circumstances and emergency actions.
- Competent authorities coordinate emergency responses and inform other Member States potentially affected.
Information Exchange and Public Consultation:
- Member States may consult with the public or interested groups on proposed contained uses.
- The Commission manages information exchange and maintains a register of accidents, supporting shared learning and improved risk management.
Inspection and Compliance: Member States must organize inspections and enforce compliance with the Directive.
Reporting: Annual and triennial reporting to the Commission about contained uses and Directive implementation is required.
Confidentiality: Competent authorities and the Commission protect confidential information and intellectual property rights submitted under the Directive, with procedures to determine confidentiality on a case-by-case basis.
Affected Products and Actors
Genetically Modified Micro-Organisms (GMMs): Defined as micro-organisms with genetically altered material through biotechnological techniques (excluding certain exempted techniques listed in Annex I B).
Users: Any natural or legal person responsible for the contained use of GMMs in installations.
Installations: Facilities where contained use operations are conducted, including research labs, industrial plants, and small-scale operations.
Competent Authorities: National authorities designated by Member States to receive notifications, assess operation conformity, grant approvals, and enforce compliance.
The European Commission: Oversees harmonized implementation, facilitates information exchange, maintains accident registers, and provides guidelines for classification and risk management.
Implementation Timeline
Notification and Consent Periods:
- For first use of installations with Group I GMMs, use may begin 90 days after notification unless the competent authority opposes earlier.
- For Group II GMMs and certain Type B operations, explicit consent from competent authorities is necessary before use can commence, to be delivered within 90 days of notification.
Reporting:
- Member States must provide annual summary reports about contained uses.
- Every three years, Member States must submit evaluations of their experience with the Directive, with the Commission publishing a summary report.
Review and Adaptation:
- A committee assists the Commission in adapting the Directive to technical progress.
- Periodic reviews of containment and safety measures by users are mandated.
This Directive took effect after its adoption on 23 April 1990 and requires Member States to transpose its provisions into national law to ensure a harmonized safety regime concerning the contained use of genetically modified micro-organisms across the European Community.
The directive applies to the contained use of genetically modified micro-organisms (GMMs), defined as microbiological entities whose genetic material has been altered through specific genetic modification techniques. The scope covers all operations involving GMMs, including their genetic modification, culturing, storage, use, transport, destruction, or disposal, provided that physical, chemical, or biological barriers are employed to limit their contact with the general population and environment. It distinguishes between small-scale, non-industrial Type A operations (e.g., for research or teaching) and larger-scale Type B operations. The directive excludes genetically modified micro-organisms produced through certain specified techniques and does not apply to transport by road, rail, inland waterway, sea, or air, nor to GMMs already placed on the market under Community legislation with equivalent risk assessments. Overall, the directive establishes safety, notification, and risk assessment requirements across sectors utilizing contained biotechnology practices involving genetically modified micro-organisms.
Die Richtlinie 90/219/EWG regelt die Anwendung genetisch veränderter Mikroorganismen (GVO) in geschlossenen Systemen zum Schutz der menschlichen Gesundheit und der Umwelt. Sie definiert zentrale Begriffe, einschließlich der Arten von Mikroorganismen und Arbeitsgängen, und legt fest, dass GVO wegen ihrer potenziellen Gefährlichkeit einer Risikobewertung unterzogen und nach Gefährlichkeitsgruppen eingeteilt werden müssen. Unternehmen oder Forschungseinrichtungen, die erstmals GVO in geschlossenen Systemen einsetzen, müssen dies bei den zuständigen Behörden anmelden und umfangreiche Informationen bereitstellen. Die Mitgliedstaaten sind verpflichtet, die Einhaltung der Sicherheit zu überwachen, Unfälle zu melden und Notfallpläne zu erstellen, um rasch gegen mögliche Gesundheits- oder Umweltrisiken reagieren zu können. Zudem sieht die Richtlinie die Förderung einer einheitlichen Regulation innerhalb der gesamten Europäischen Gemeinschaft vor, einschließlich Informationsaustauschs über Unfälle und Risiken auf Gemeinschaftsebene. So soll eine sichere und kontrollierte Weiterentwicklung der Biotechnologie in der EU gewährleistet werden.
Zweck
Die Richtlinie 90/219/EWG legt gemeinsame Maßnahmen für die Anwendung genetisch veränderter Mikroorganismen (GVO) in geschlossenen Systemen fest. Ziel ist es, die menschliche Gesundheit und die Umwelt vor möglichen schädlichen Auswirkungen zu schützen, die durch den Umgang mit solchen Mikroorganismen entstehen können. Dabei wird dem Vorsorgeprinzip Rechnung getragen, um Umweltbeeinträchtigungen vorzubeugen. Die Richtlinie stellt sicher, dass bei der Nutzung der Biotechnologie ein hohes Sicherheitsniveau gewahrt bleibt, einschließlich Unfallverhütung, Abfallbewirtschaftung und Informationsaustausch. Im Mittelpunkt steht die Risikobewertung auf Basis des Gefährlichkeitsgrades der eingesetzten Mikroorganismen sowie entsprechende Vorsichts- und Einschließungsmaßnahmen während der gesamten Anwendung.
Wichtige Verpflichtungen
Risikobewertung: Anwender müssen vor der Nutzung genetisch veränderter Mikroorganismen eine Vorabbewertung der damit verbundenen Risiken für Gesundheit und Umwelt durchführen und dokumentieren. Diese Bewertung basiert auf den Kriterien des Anhangs III der Richtlinie.
Klassifizierung: GVO werden in zwei Gruppen (Gruppe I und II) eingeteilt, abhängig von ihrem Gefährlichkeitsgrad. Abhängig davon gelten unterschiedliche Anforderungen an Sicherheitsmaßnahmen und Anmeldeverfahren.
Anmeldung und Genehmigung: Je nach Gefährlichkeitsklasse und Art des Arbeitsgangs (Typ A: kleinmaßstäblich/forschungsbezogen; Typ B: andere Anwendungen) müssen Anwender den zuständigen Behörden detaillierte Anmeldungen vorlegen. Für Gruppe II und Typ-B-Arbeitsgänge ist vor Beginn eine behördliche Zustimmung erforderlich.
Sicherheitsmaßnahmen: Durchführung geeigneter Einschließungsmaßnahmen, guter mikrobiologischer Praxis und spezifischer Schutzmaßnahmen zum Schutz am Arbeitsplatz und der Umwelt. Maßnahmen sind regelmäßig zu überprüfen und an neue wissenschaftliche Erkenntnisse anzupassen.
Unfallmanagement: Anwender müssen unverzüglich alle Unfälle, die eine Freisetzung genetisch veränderter Mikroorganismen verursachen könnten, der zuständigen Behörde melden und umfassende Informationen bereitstellen. Die Mitgliedstaaten sind verpflichtet, effektive Notfallpläne zu entwickeln, betroffene Personen zu informieren und gegebenenfalls gegenseitig zu warnen.
Information und Anhörung: Mitgliedstaaten können öffentliche Anhörungen zu geplanten Anwendungen anordnen. Zudem soll die Öffentlichkeit und betroffene Personen über Sicherheitsaspekte und Notfallverhalten informiert und sensibilisiert werden.
Überwachung und Informationsaustausch: Die Mitgliedstaaten übermitteln der Kommission Angaben zu den Anwendungen in ihren Gebieten. Die Kommission organisiert einen Informationsaustausch über Unfälle und führt ein Unfallverzeichnis.
Betroffene Produkte und Akteure
Genetisch veränderte Mikroorganismen (GVO): Jegliche mikrobiologischen Einheiten (zellulär oder nichtzellulär), die genetisch verändert wurden, soweit dies nicht durch natürliche Kreuzen oder Rekombination erklärbar ist.
Anwender: Natürliche oder juristische Personen, die für die Anwendung genetisch veränderter Mikroorganismen in geschlossenen Systemen verantwortlich sind.
Anlagen und Einrichtungen: Orte, an denen Vermehrung, Lagerung, Nutzung, Transport oder Beseitigung genetisch veränderter Mikroorganismen unter physikalischen und ggf. chemischen oder biologischen Schranken stattfinden.
Behörden: Nationale zuständige Behörden der Mitgliedstaaten, die Anmeldungen prüfen, Genehmigungen erteilen, Überwachung durchführen und im Unfallfall reagieren.
Öffentlichkeit und betroffene Gruppen: Personen, die eventuell von einer Anwendung oder einem Unfall betroffen sein könnten; ebenfalls können Interessengruppen zu Anhörungen eingeladen werden.
Umsetzungszeitplan
Die Richtlinie trat am 23. April 1990 in Kraft.
Vor der erstmaligen Anwendung genetisch veränderter Mikroorganismen in einer Anlage muss eine Anmeldung erfolgen. Für Gruppe I ohne ausdrückliche ablehnende Entscheidung der Behörde kann die Anwendung 90 Tage nach Anmeldung beginnen; für Gruppe II ist eine ausdrückliche behördliche Zustimmung erforderlich.
Fristen für Entscheidungen der Behörden: Die zuständigen Behörden sollen spätestens 90 Tage nach Anmeldung ihre Entscheidung bekanntgeben. Bei Typ-A-Arbeitsgängen der Gruppe I bzw. II kann die Anwendung unter bestimmten Umständen auch nach 60 Tagen starten, wenn keine gegenteilige Anweisung erfolgt.
Laufende Überwachung: Verantwortliche Anwender müssen Änderungen, die Risiken beeinflussen, unverzüglich melden und Sicherheitsmaßnahmen regelmäßig aktualisieren.
Die Kommission richtet in Abstimmung mit den Mitgliedstaaten Verfahren für Informationsaustausch und Unfallstatistik ein.
Die Umsetzung der Richtlinie verlangt von den Mitgliedstaaten die Schaffung nationaler Regelungen zur Kontrolle, Überwachung und Koordinierung der Anwendung genetisch veränderter Mikroorganismen in geschlossenen Systemen gemäß ihren technischen und rechtlichen Vorgaben.
Die Richtlinie 90/219/EWG gilt für die Anwendung genetisch veränderter Mikroorganismen in geschlossenen Systemen. Dies umfasst Arbeitsgänge, bei denen Mikroorganismen genetisch verändert oder genetisch veränderte Mikroorganismen vermehrt, gelagert, verwendet, transportiert, zerstört oder beseitigt werden, wobei physikalische und gegebenenfalls chemische oder biologische Schranken eingesetzt werden, um den Kontakt mit der Bevölkerung und der Umwelt zu begrenzen. Sie richtet sich an Tätigkeiten in verschiedenen Bereichen der Biotechnologie, insbesondere solche, die in Lehr-, Forschungs- und Entwicklungsumgebungen sowie industriellen oder kommerziellen Maßstäben durchgeführt werden. Die Richtlinie schließt den Transport genetisch veränderter Mikroorganismen auf öffentlichen Verkehrswegen sowie die Lagerung, Zerstörung oder Beseitigung im Rahmen anderer gemeinschaftlicher Rechtsvorschriften aus. Ziel ist es, Risiken für die menschliche Gesundheit und die Umwelt durch geeignete Sicherheitsmaßnahmen, Risikobewertung und Überwachung zu minimieren.
La directive 90/219/CEE établit un cadre commun pour l'utilisation confinée des micro-organismes génétiquement modifiés (MGM) dans l'Union européenne afin de protéger la santé humaine et l'environnement. Elle définit les termes clés, classe les MGM en groupes de risques et impose des mesures strictes de confinement, d'évaluation et de gestion des risques pour toute opération impliquant des MGM, qu'il s'agisse de recherche, de développement ou d'utilisation industrielle. Avant toute utilisation confinée, une notification détaillée doit être soumise aux autorités compétentes qui évaluent les risques et peuvent exiger des modifications ou autorisations spécifiques. La directive prévoit également des exigences pour la gestion des accidents, incluant l'information immédiate des autorités et l'établissement de plans d'urgence. Elle encourage la consultation publique lorsque nécessaire et impose aux États membres de mettre en place des systèmes de surveillance et d'échange d'informations pour assurer une gestion sûre et harmonisée des MGM dans la Communauté. Ces mesures visent à garantir un développement biotechnologique sécurisé, respectant le principe de précaution.
Objet
La directive 90/219/CEE du Conseil du 23 avril 1990 établit un cadre réglementaire commun pour l’utilisation confinée des micro-organismes génétiquement modifiés (MGM) au sein de la Communauté européenne. Son objectif principal est la protection de la santé humaine et de l’environnement en encadrant strictement les opérations impliquant ces micro-organismes, notamment pour prévenir les risques liés à la dissémination accidentelle et garantir une gestion sécurisée à toutes les étapes de leur utilisation confinée.
Cette directive souligne la nécessité d’une évaluation préalable des risques et d’une classification des MGM selon leur dangerosité, ainsi qu’un contrôle rigoureux des conditions techniques et organisationnelles de confinement.
Obligations clés
Définition et classification : Les micro-organismes génétiquement modifiés sont définis et classés en groupes selon les risques qu’ils posent (groupe I et II). Cette classification sert de base aux mesures de sécurité à appliquer.
Évaluation des risques : Avant toute utilisation confinée, l’utilisateur doit réaliser une évaluation des risques spécifiques à la santé humaine et à l’environnement, en se référant aux paramètres détaillés à l’annexe III de la directive.
Notification préalable : Toute première utilisation confinée d’un MGM dans une installation doit être notifiée à l’autorité compétente avec un dossier complet (voir annexes V A à V D selon le type et le groupe du micro-organisme). Certaines opérations de type B ou impliquant des MGM du groupe II nécessitent une autorisation préalable explicite de l’autorité.
Mesures de confinement : Mise en œuvre de barrières physiques, chimiques et/ou biologiques, ainsi que de bonnes pratiques microbiologiques et professionnelles pour limiter l’exposition et maîtriser les émissions. Ces mesures sont adaptées selon la classification du micro-organisme et le type d’opération.
Gestion des incidents : En cas d’accident (dissémination involontaire importante), l’utilisateur doit immédiatement informer l’autorité compétente et fournir toutes les informations nécessaires pour évaluer les conséquences et prendre des mesures adéquates. Les États membres doivent aussi établir des plans d’urgence et informer le public concerné.
Surveillance et information : Les autorités compétentes examinent la conformité des notifications, peuvent demander des informations complémentaires, imposer des conditions ou suspendre les opérations si nécessaire. Une communication transnationale est prévue en cas d’incidents affectant plusieurs États membres.
Consultation du public : Un mécanisme facultatif de consultation publique ou de groupes spécialisés est prévu pour certaines utilisations confinées, en fonction des risques.
Produits et acteurs concernés
Micro-organismes ciblés : Toute entité microbiologique génétiquement modifiée, cellulaire ou non cellulaire, susceptible de se reproduire ou transférer du matériel génétique, sauf exceptions relatives à certaines techniques de modification listées à l’annexe I B.
Utilisateurs : Personnes physiques ou morales responsables de l’utilisation confinée des MGM (laboratoires de recherche, institutions de développement biotechnologique, industries utilisant des biotechnologies en espace confiné).
Autorités compétentes : Désignées par chaque État membre pour recevoir les notifications, contrôler les procédures d’autorisation, effectuer un suivi et assurer la communication des informations au sein de la Communauté.
Opérations couvertes : Selon le niveau d’intensité et le but, les opérations sont classées en type A (petite échelle, non commerciale) et type B (plus large, industrielle ou commerciale). La directive ne s’applique pas au transport international ou au stockage des MGM déjà réglementés par d’autres normes communautaires.
Calendrier de mise en œuvre
La directive est entrée en vigueur peu après son adoption en 1990, les États membres devant prendre les mesures nécessaires pour transposer ses dispositions dans leur droit national dans un délai raisonnable après publication.
La Commission européenne prévoit l’élaboration de lignes directrices pour la classification des MGM avant la pleine application de la directive.
Les délais spécifiques pour le traitement des notifications varient entre 60 et 90 jours selon le groupe du micro-organisme et le type d’opération, avec possibilité d’approbation préalable plus rapide en l’absence d’observations des autorités compétentes.
Les mesures concernant la gestion des accidents, l’information du public et la coopération entre États membres sont immédiatement applicables pour garantir une surveillance continue et partagée des risques liés à l’utilisation confinée des MGM.
Cette directive établit ainsi un cadre harmonisé pour assurer un développement sûr et contrôlé des biotechnologies impliquant des micro-organismes génétiquement modifiés dans l’espace communautaire, conciliant innovations scientifiques et protection sanitaire et environnementale.
La directive 90/219/CEE s’applique à l’utilisation confinée de micro-organismes génétiquement modifiés, c'est-à-dire toute opération impliquant la modification génétique ou le stockage, l’utilisation, le transport, la destruction ou l’élimination de tels micro-organismes dans des conditions restrictives visant à limiter leur contact avec la population et l’environnement. Elle couvre les micro-organismes modifiés par certaines techniques spécifiques listées à l’annexe I.A, excluant celles de l’annexe I.B. La directive concerne aussi bien les opérations à petite échelle à des fins non commerciales ou de recherche que les opérations industrielles ou commerciales à plus grande échelle. Elle ne s’applique pas au transport routier, ferroviaire, maritime ou aérien, ni à la gestion de micro-organismes déjà mis sur le marché selon une autre réglementation communautaire. Elle vise à garantir la protection de la santé humaine et de l’environnement en encadrant rigoureusement ces activités au sein de l’Union européenne.
Direktiva 90/219/EGS določa skupne ukrepe za uporabo gensko spremenjenih mikroorganizmov (GSM) v zaprtih sistemih z namenom varovanja zdravja ljudi in okolja v Evropski skupnosti. Določa definicije GSM, razvrščanje glede na tveganje ter zahteve za oceno tveganja, prijavo in uporabo GSM. Uporabniki morajo izvajati varnostne ukrepe, vključno z dobrimi mikrobiološkimi praksami in nadzorom emisij ter preprečevanjem nesreč. Pred prvo uporabo GSM v zaprtem sistemu je potrebna prijava pristojnim organom, ki ocenijo tveganja in pogoje uporabe. Direktiva zahteva tudi načrte za primere nesreč, obveščanje javnosti in sodelovanje držav članic pri izmenjavi informacij ter inšpekcijske nadzore. Namen je usmerjen v preventivo in varno uporabo biotehnologije z omejevanjem morebitnih škodljivih vplivov, hkrati pa omogoča gospodarski razvoj na področju biotehnologije v Skupnosti. Države članice morajo uskladiti nacionalne predpise s to direktivo do oktobra 1991.
Namen
Direktiva 90/219/EGS določa skupne ukrepe za uporabo gensko spremenjenih mikroorganizmov (GSM) v zaprtih sistemih z namenom zaščite zdravja ljudi in okolja. Uvaja preventivne ukrepe, ki temeljijo na oceni tveganj za omejitev negativnih vplivov, povezanih z uporabo GSM. Direktiva prizna potrebo po usklajenih postopkih ocenjevanja tveganj in določitvi pogojev uporabe GSM znotraj evropskih držav članic, saj se lahko mikroorganizmi razširijo čez državne meje. Vključen je tudi vidik obveščanja javnosti in priprave načrtov za primere nesreč.
Ključne obveznosti
Ocena tveganja: Uporabniki GSM v zaprtih sistemih morajo izvesti predhodno oceno tveganja za zdravje ljudi in okolje (člen 6). Ocena temelji na parametrih, navedenih v prilogi III.
Razvrščanje mikroorganizmov: GSM se razvršča v dve skupini glede na raven tveganja – skupina I (nižja tveganja) in skupina II (višja tveganja) (člen 4).
Prijava:
- Ob prvem uvajanju obratov za uporabo GSM je obvezna prijava pristojnemu organu za preverjanje varnosti (člen 8).
- Prijave so zahtevane glede na skupino GSM in tip postopka (členi 9 in 10).
Nadzor in dovoljenja: Uporaba GSM skupine II in postopkov višjega tveganja zahteva odobritev pristojnih organov. Uporaba skupine I lahko začne delovanje po 60-90 dneh od vložitve prijave, če ni ugovora (člen 11).
Varnostni ukrepi: Uporabniki morajo upoštevati načela dobre mikrobiološke prakse in varnostne ukrepe, ki vključujejo tehnične kontrole, osebno zaščitno opremo, redno preverjanje zadrževalnih ukrepov in usposabljanje osebja (člen 7).
Nesreče: Uporabniki morajo nemudoma obvestiti pristojne organe o nesrečah in zagotoviti podrobne informacije o sproščenih GSM ter ukrepih za omejitev škode (členi 15 in 16).
Obveščanje javnosti in načrti za nesreče: Države članice lahko izvedejo posvetovanja z javnostjo, prav tako pa morajo zagotavljati informacije in pripraviti načrte ukrepov za nesreče (člen 13, 14).
Inšpekcija in nadzor: Pristojni organi izvajajo inšpekcijske preglede za zagotavljanje skladnosti z direktivo (člen 17).
Zaupnost podatkov: Zagotovljena je zaščita zaupnih informacij, vendar ne na račun ključnih varnostnih in varovalnih podatkov (člen 19).
Vplivani proizvodi in akterji
- Gensko spremenjeni mikroorganizmi (GSM), definirani kot mikrobiološke enote z gensko spremembo, ki ni dosežena naravno (člen 2).
- Uporabniki GSM, torej fizične ali pravne osebe, ki izvajajo postopke z GSM v zaprtih sistemih.
- Pristojni organi držav članic, ki nadzorujejo in odobrijo uporabo ter spremljajo varnost.
- Obrati in institucije, kjer se izvaja genskospremenska dejavnost v zaprtih sistemih.
- Javna skupnost, vključena v posvetovanja o varnosti GSM in obveščanje o potencialnih tveganjih.
Časovni okvir za implementacijo
- Države članice so morale sprejeti potrebne zakone in uredbe za uskladitev s to direktivo do 23. oktobra 1991 (člen 22).
- Obvezno poročanje Komisiji o uporabi in izkušnjah z direktivo poteka letno oziroma vsaka tri leta (člen 18).
- Začetek uporabe GSM v novih obratih je povezano z roki za odobritev, ki so največ 60-90 dni od datuma prijave (člen 11).
Direktiva je torej ključni pravni okvir za varno in nadzorovano uporabo gensko spremenjenih mikroorganizmov v Evropski uniji, usmerjena predvsem v preprečevanje škodljivih vplivov na zdravje ljudi in okolje ob hkratnem podajanju jasnih in usklajenih postopkov za akterje na tem področju.
Direktiva 90/219/EEC se uporablja za gensko spremenjene mikroorganizme, ki se uporabljajo v zaprtih sistemih. Vključuje postopke, kjer se gensko spremenjeni mikroorganizmi gojijo, shranjujejo, uporabljajo, prenašajo, uničujejo ali odstranjujejo ob uporabi fizičnih, kemičnih in/ali bioloških zapor za omejevanje stika z ljudmi in okoljem. Namen je varovanje zdravja ljudi in okolja pred morebitnimi negativnimi učinki uporabe takšnih mikroorganizmov v različnih vrstah aktivnosti, kot so raziskave, razvoj, nevzdržno industrijsko in nekomercialno delo. Direktiva določa zahteve za oceno tveganja, nadzor, prijavo in spremljanje uporabe gensko spremenjenih mikroorganizmov v zaprtih sistemih v državah članicah EU. Iz nje so izvzeti mikroorganizmi, pri katerih je genska sprememba dosežena z določenimi metodami, ter primeri prevoza in trženja, če so pokriti z drugo zakonodajo Skupnosti.
General Information
This document gives requirements and recommendations for installation, commissioning and routine testing of BSC.
- Standard16 pagesEnglish languagee-Library read for1 day
This document specifies the specific requirements for class II BSC with respect to design, construction, safety and hygiene.
It sets the specific performance criteria for class II BSC for work with biological agents and specifies test procedures with respect to protection of the worker, the environment and product protection including cross-contamination.
- Standard43 pagesEnglish languagee-Library read for1 day
This document specifies the minimum requirements for BSC with respect to design, construction, safety and hygiene and gives general test methods for their verification.
The requirements for the different classes are given in the respective parts of EN 12469.
- Standard24 pagesEnglish languagee-Library read for1 day
This document specifies the specific requirements for class II BSC with respect to design, construction, safety and hygiene.
It sets the specific performance criteria for class II BSC for work with biological agents and specifies test procedures with respect to protection of the worker, the environment and product protection including cross-contamination.
- Standard43 pagesEnglish languagee-Library read for1 day
This document gives requirements and recommendations for installation, commissioning and routine testing of BSC.
- Standard16 pagesEnglish languagee-Library read for1 day
This document specifies the minimum requirements for BSC with respect to design, construction, safety and hygiene and gives general test methods for their verification.
The requirements for the different classes are given in the respective parts of prEN 12469.
- Standard24 pagesEnglish languagee-Library read for1 day
This European Standard gives biological, physical and procedural containment measures for work with genetically modified plants including plants where the transferred genetic material is derived from a non-plant source. It defines measures to minimize hazards identified by risk analysis.
Containment may be provided in a greenhouse or in a growthroom, laboratory or other containment facility.
Containment of genetically modified microorganisms and/or small animals associated with plants is not included in this standard. Containment of microorganisms in laboratories is covered in EN 12128.
- Standard10 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for bioreactors used in biotechnological processes with respect to the potential risks to the worker and the environment from microorganisms in use. This European Standard applies where the intended use of bioreactors includes hazardous or potentially hazardous microorganisms used in biotechnological processes or where exposure of the worker or the environment to such microorganisms is restricted for reasons of safety.
- Standard10 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for kill tanks used in biotechnological processes with respect to the potential risks to the worker and the environment from microorganisms in use. This European Standard applies where the intended use of kill tanks includes hazardous or potentially hazardous microorganisms used in biotechnological processes or where exposure of the worker or the environment to such microorganisms is restricted for reasons of safety.
- Standard11 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for chromatography columns used in biotechnological processes with respect to the potential risks to the worker and the environment from microorganisms in use. This European Standard applies where the intended use of chromatography columns includes hazardous or potentially hazardous microorganisms used in biotechnological processes or where exposure of the worker or the environment to such microorganisms is restricted for reasons of safety.
- Standard8 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for equipment probes used in biotechnological processes with respect to the potential risks to the worker and the environment from microorganisms in use. This European Standard applies where the intended use of the equipment probes includes hazardous or potentially hazardous microorganisms used in biotechnological processes or where exposure of the worker or the environment to such microorganisms is restricted for reasons of safety.
- Standard8 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for tubes and pipes used in biotechnological processes with respect to the potential risks to the worker and the environment from microorganisms in use. This European Standard applies where the intended use of the tubes and pipes includes hazardous or potentially hazardous microorganisms used in biotechnological processes or where exposure of the worker or the environment to such microorganisms is restricted for reasons of safety.
- Standard9 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for couplings used in biotechnological processes with respect to the potential risks to the worker and the environment from microorganisms in use. This European Standard applies where the intended use of the coupling includes hazardous or potentially hazardous microorganisms used in biotechnological processes or where exposure of the worker or the environment to such microorganisms is restricted for reasons of safety.
- Standard9 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for pressure protection devices used in biotechnological processes with respect to the potential risks to the worker and the environment from microorganisms in use. This European Standard applies where the intended use of pressure protection devices includes hazardous or potentially hazardous microorganisms used in biotechnological processes.
- Standard8 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for vessels used in biotechnological processes with respect to the potential risks to the worker and the environment from microorganisms in use. This European Standard applies where the intended use of the equipment includes hazardous or potentially hazardous microorganisms used in biotechnological processes or where exposure of the worker or the environment to such microorganisms is restricted for reasons of safety.
- Standard13 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for sampling and inoculation devices used in biotechnological processes with respect to the potential risks to the worker and the environment from microorganisms in use. This European Standard applies where the intended use of the sampling and inoculation device includes hazardous or potentially hazardous microorganisms used in biotechnological processes or where exposure of the worker or the environment to such microorganisms is restricted for reasons of safety.
- Standard17 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for glass pressure vessels used in biotechnological processes with respect to the potential risks to the worker and the environment from microorganisms in use. This European Standard applies where the intended use of glass pressure vessels includes hazardous or potentially hazardous microorganisms used in biotechnological processes or where exposure of the worker or the environment to such microorganisms is restricted for reasons of safety.
- Standard9 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for valves used in biotechnological processes with respect to the potential risks to the worker and the environment from microorganisms in use. This European Standard applies where the intended use of the valve includes hazardous or potentially hazardous microorganisms used in biotechnological processes or where exposure of the worker or the environment to such microorganisms is restricted for reasons of safety.
- Standard10 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for piping and instrumentation used in biotechnological processes with respect to the potential risks to the worker and the environment from microorganisms in use. This European Standard applies where the intended use of the equipment includes hazardous or potentially hazardous microorganisms used in biotechnological processes or where exposure of the worker or the environment to such microorganisms is restricted for reasons of safety.
- Standard13 pagesEnglish languagee-Library read for1 day
This European Standard gives biological, physical and procedural containment measures for work with genetically modified plants including plants where the transferred genetic material is derived from a non-plant source. It defines measures to minimize hazards identified by risk analysis.
Containment may be provided in a greenhouse or in a growthroom, laboratory or other containment facility.
Containment of genetically modified microorganisms and/or small animals associated with plants is not included in this standard. Containment of microorganisms in laboratories is covered in EN 12128.
- Standard10 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for vessels used in biotechnological processes with respect to the potential risks to the worker and the environment from microorganisms in use. This European Standard applies where the intended use of the equipment includes hazardous or potentially hazardous microorganisms used in biotechnological processes or where exposure of the worker or the environment to such microorganisms is restricted for reasons of safety.
- Standard13 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for bioreactors used in biotechnological processes with respect to the potential risks to the worker and the environment from microorganisms in use. This European Standard applies where the intended use of bioreactors includes hazardous or potentially hazardous microorganisms used in biotechnological processes or where exposure of the worker or the environment to such microorganisms is restricted for reasons of safety.
- Standard10 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for chromatography columns used in biotechnological processes with respect to the potential risks to the worker and the environment from microorganisms in use. This European Standard applies where the intended use of chromatography columns includes hazardous or potentially hazardous microorganisms used in biotechnological processes or where exposure of the worker or the environment to such microorganisms is restricted for reasons of safety.
- Standard8 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for kill tanks used in biotechnological processes with respect to the potential risks to the worker and the environment from microorganisms in use. This European Standard applies where the intended use of kill tanks includes hazardous or potentially hazardous microorganisms used in biotechnological processes or where exposure of the worker or the environment to such microorganisms is restricted for reasons of safety.
- Standard11 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for pressure protection devices used in biotechnological processes with respect to the potential risks to the worker and the environment from microorganisms in use. This European Standard applies where the intended use of pressure protection devices includes hazardous or potentially hazardous microorganisms used in biotechnological processes.
- Standard8 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for glass pressure vessels used in biotechnological processes with respect to the potential risks to the worker and the environment from microorganisms in use. This European Standard applies where the intended use of glass pressure vessels includes hazardous or potentially hazardous microorganisms used in biotechnological processes or where exposure of the worker or the environment to such microorganisms is restricted for reasons of safety.
- Standard9 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for equipment probes used in biotechnological processes with respect to the potential risks to the worker and the environment from microorganisms in use. This European Standard applies where the intended use of the equipment probes includes hazardous or potentially hazardous microorganisms used in biotechnological processes or where exposure of the worker or the environment to such microorganisms is restricted for reasons of safety.
- Standard8 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for sampling and inoculation devices used in biotechnological processes with respect to the potential risks to the worker and the environment from microorganisms in use. This European Standard applies where the intended use of the sampling and inoculation device includes hazardous or potentially hazardous microorganisms used in biotechnological processes or where exposure of the worker or the environment to such microorganisms is restricted for reasons of safety.
- Standard17 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for tubes and pipes used in biotechnological processes with respect to the potential risks to the worker and the environment from microorganisms in use. This European Standard applies where the intended use of the tubes and pipes includes hazardous or potentially hazardous microorganisms used in biotechnological processes or where exposure of the worker or the environment to such microorganisms is restricted for reasons of safety.
- Standard9 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for valves used in biotechnological processes with respect to the potential risks to the worker and the environment from microorganisms in use. This European Standard applies where the intended use of the valve includes hazardous or potentially hazardous microorganisms used in biotechnological processes or where exposure of the worker or the environment to such microorganisms is restricted for reasons of safety.
- Standard10 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for piping and instrumentation used in biotechnological processes with respect to the potential risks to the worker and the environment from microorganisms in use. This European Standard applies where the intended use of the equipment includes hazardous or potentially hazardous microorganisms used in biotechnological processes or where exposure of the worker or the environment to such microorganisms is restricted for reasons of safety.
- Standard13 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for couplings used in biotechnological processes with respect to the potential risks to the worker and the environment from microorganisms in use. This European Standard applies where the intended use of the coupling includes hazardous or potentially hazardous microorganisms used in biotechnological processes or where exposure of the worker or the environment to such microorganisms is restricted for reasons of safety.
- Standard9 pagesEnglish languagee-Library read for1 day
This European Standard specifies basic requirements for microbiological safety cabinets (MSCs) with respect to safety and hygiene. This European Standard sets the minimum performance criteria for safety cabinets for work with microorganisms and specifies test procedures for microbiological safety cabinets with respect to protection of the worker and the environment, product protection and cross contamination. Mechanical, electrical, chemical or radioactive safety precautions are not covered in the standard but are covered in EN 610101-1, EN 292-1 and EN 292-2 (see Bibliography (1), (2) and (3)).
- Standard45 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for off-gas systems used in biotechnological processes with respect to the potential risks of microorganisms in use for the worker and the environment. This European Standard applies where the intended use of the off-gas system includes hazardous or potentially hazardous microorganisms used in biotechnological processes and/or where exposure of the worker or the environment to such microorganisms is restricted for reasons of safety.
- Standard16 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for filter elements and filtration assemblies used in biotechnological processes with respect to the potential risks of microorganisms in use for the worker and the environment. This European Standard applies where the intended use of the filter elements or filtration assemblies includes hazardous or potentially hazardous microorganisms used in biotechnological processes and/or where exposure of the worker or the environment to such microorganisms is restricted for reasons of safety.
- Standard19 pagesEnglish languagee-Library read for1 day
This European Standard specifies basic requirements for microbiological safety cabinets (MSCs) with respect to safety and hygiene. This European Standard sets the minimum performance criteria for safety cabinets for work with microorganisms and specifies test procedures for microbiological safety cabinets with respect to protection of the worker and the environment, product protection and cross contamination. Mechanical, electrical, chemical or radioactive safety precautions are not covered in the standard but are covered in EN 610101-1, EN 292-1 and EN 292-2 (see Bibliography (1), (2) and (3)).
- Standard45 pagesEnglish languagee-Library read for1 day
This European Standard gives guidance to the manufacturer of sampling and inoculation devices on providing instructions in the manufacturer's documentation accompanying his products in accordance with prEN 13312-3. It has the purpose of pointing out to him, which hazards can occur during operation, s so that he can take these into account in an adequate way during construction and will be in a positive to formulate information for use giving adequate consideration of safety...
- Standard13 pagesEnglish languagee-Library read for1 day
This European Standard gives guidance to the manufacturer of sampling and inoculation devices on providing instructions in the manufacturer's documentation accompanying his products in accordance with prEN 13312-3. It has the purpose of pointing out to him, which hazards can occur during operation, s so that he can take these into account in an adequate way during construction and will be in a positive to formulate information for use giving adequate consideration of safety...
- Standard13 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for off-gas systems used in biotechnological processes with respect to the potential risks of microorganisms in use for the worker and the environment. This European Standard applies where the intended use of the off-gas system includes hazardous or potentially hazardous microorganisms used in biotechnological processes and/or where exposure of the worker or the environment to such microorganisms is restricted for reasons of safety.
- Standard16 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for filter elements and filtration assemblies used in biotechnological processes with respect to the potential risks of microorganisms in use for the worker and the environment. This European Standard applies where the intended use of the filter elements or filtration assemblies includes hazardous or potentially hazardous microorganisms used in biotechnological processes and/or where exposure of the worker or the environment to such microorganisms is restricted for reasons of safety.
- Standard19 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for cell disrupters used in the biotechnological processes with respect to the potential risks of microorganisms in use for the worker or the environment. This European Standard applies where the intended use of the cell disrupter includes hazardous or potentially hazardous microorganisms used in biotechnological processes and/or where exposure of the worker or the environment to such microorganisms is restricted for reasons of safety.
- Standard13 pagesEnglish languagee-Library read for1 day
This European Standard provides guidance for factors and criteria considered by the experimenter for the valid design, execution and evaluation of an analysis of the molecular stability of the genomic modification with respect to life cycle, heritability and external factors. It describes the steps in the characterization of a GMO that should be followed to ensure the validity of the analysis of the molecular stability of the genomic modification. The type of molecular stability analysis is dependent on the objectives of the experiment.
- Standard16 pagesEnglish languagee-Library read for1 day
This European Standard gives guidance on methods for handling, inactivating and testing of waste containing organisms arising from biotechnology laboratory activities and processes. It is concerned with methods to reduce the risks arising from exposure to waste derived from laboratory-scale activities which contains organisms hazardous or potentially hazardous to humans, animals, plants or the environment.
- Standard21 pagesEnglish languagee-Library read for1 day
This European Standard specifies design requirements for plant buildings used for the safe handling of microorganisms and the product itself if it presents a biohazard. Note 1: When applying this European Standard, attention is drawn to the existing national regulations such as regulations concerning genetic engineering, water and environmental emission concerning the design requirements.
- Standard16 pagesEnglish languagee-Library read for1 day
This European Standard specifies minimum physical requirements for biological safety for laboratories at four reference physical containment levels which are appropriate for handling microorganisms of different risk groups. This European Standard primarily addresses the containment of microorganisms which can present a risk to human health. It applies to microbiology laboratories where the handling of microorganisms in bacteriology, mycology, virology, parasitology and/or genetic modification is carried out.
- Standard22 pagesEnglish languagee-Library read for1 day
This European Standard, in order to protect the worker and/or the environment, gives guidance on minimum physical biosafety measures for the containment of animals deliberately inoculated with microorganisms, including genetically modified microorganisms, which can present a risk to human or animal health or the environment. This European Standard does not apply to the containment of animals which have not been deliberately inoculated with microorganisms.
- Standard15 pagesEnglish languagee-Library read for1 day
This European Standard provides guidance for a quality control procedure of a diagnostic kit to assure that the assay results will fulfil the intended purpose of the test by both manufacturers and users. This European Standard applies to diagnostic kits used in agriculture, plant and animal pest and disease control monitoring of feed and environmental contamination due to microorganisms.
- Standard9 pagesEnglish languagee-Library read for1 day
This European Standard specifies performance criteria for pumps used in biotechnological processes, in which the release of microorganisms should be limited or prevented for reasons of safety. This standard applies if the intended use of the pump includes hazardous or potentially hazardous microorganisms. This standard applies to pumps with no auxiliary equipment, bordered by the connections on the unit of equipment. It also applies to pump systems equipped with all necessary auxiliary equipment necessary for operation of pumps and to accomplish cleaning and sterilization.
- Standard13 pagesEnglish languagee-Library read for1 day
This European Standard provides guidance concerning the procedures for setting up a valid sampling strategy to meet the objectives of a monitoring strategy for GMMs released into the environment. Since monitoring methods of microorganisms in environmental samples usually require pretreatment of the samples, for example the extraction and isolation of GMMs and/or their nucleic acid, this is included in scope of this European Standard. The sampling is to provide material to which subsequent analytical or biological methods for monitoring of GMMs can be applied.
- Standard12 pagesEnglish languagee-Library read for1 day
This European Standard gives guidance on the assessment and the selection of procedures for treatment of waste process microorganisms from biotechnological plant to ensure the safety of people and environment. This European Standard applies to wastes and effluents (solid, liquid and gaseous) emitted from biotechnological processes which include traditional processes such as brewing or food processing, fermentation of pharmaceutical and chemical products as well as biotechnological processes for environmental and agricultural application.
- Standard18 pagesEnglish languagee-Library read for1 day
Frequently Asked Questions
An EU Directive is a legislative act of the European Union that sets out goals that all EU member states must achieve. However, it is up to each member state to devise their own laws on how to reach these goals through national transposition. Directives are used to harmonize laws across the EU, particularly for the functioning of the single market.
Directive 90/219/EEC covers "Contained use of genetically modified micro-organisms". There are 106 standards associated with this directive.
Harmonized standards under 90/219/EEC are European standards (ENs) developed by CEN, CENELEC, or ETSI in response to a mandate from the European Commission. When these standards are cited in the Official Journal of the European Union, products manufactured in conformity with them benefit from a presumption of conformity with the essential requirements of 90/219/EEC, facilitating CE marking and free movement within the European Economic Area.